← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 30, 2004Last known activity
Jun 15, 2017
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 3 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (5)
- NCT03376698Reponsible party - principal investigatorPhase 2Jun 15, 2017
- NCT03376698Lead sponsorPhase 2Jun 15, 2017
- NCT02330406Overall official - principal investigatorPhase 4Jan 1, 2015
- NCT00131846CollaboratorPhase 4Apr 30, 2004
- NCT00131846OfficialPhase 4Apr 30, 2004
Details
- Last known activity
- Jun 15, 2017